by Anton Basenko
Let’s agree that hepatitis can’t wait. That means that treatment should be there immediately and access should be really simple, like fast-track access to viral hepatitis treatment for people living with HIV and people from key affected communities.
By Cianán B. Russell
In moments like these, where even our former allies are using us to advance their own political goals, pride and its value become ever clearer. Pride is our moment – one where we come together to heal, to regroup, to celebrate the beauty and brilliance of LGBTI people, and remains, at its core, a reminder to ourselves that we must continue to fight.
by Julian Hows
Great that PRIDE continues to evolve, to continue to be a broad tent, with many flags and factions – that there is no ONE way of being different – and we can explore how different, outrageous, shocking, connected to each other we can be.
by Yves Leroy
40 years ago, June 5th 1981, American medical authorities were warning of a disease that would become AIDS. Maxime Journiac contracted the virus one year later. He agreed to tell us about four decades of fighting.
By Gus Cairns
I just wanted to honour the unacknowledged lives and forgotten deaths of the people who died in places like Kinshasa and Rakai long before New Yorkers started getting it. But also to expose my own ambiguity and discomfort with the label ‘Long Term Survivor’ of HIV. My life would have been very different, and possibly in some ways better, if AIDS had not happened. I celebrate the fact that that experience is unlikely to happen again for people diagnosed in the last two decades. It’s wonderful. But survival, as well as being wonderful, has a price.
By Lisa Power
Community Advisory Boards (CABs) are a growing feature of patient engagement strategies to inform and improve drug development within a range of medical conditions. The creation of these ongoing expert patient consultative panels has made substantial contributions to improved drug development but more systematic evaluation of the evidence is needed. While many CABs are national, they can also work across Europe and the longest-running of these is the European AIDS Treatment Group’s CAB.
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.